Portal de investigación
GEDEFO-SEFH management of antineoplastic extravasations survey results.
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Jiménez-Pulido I
- Conde-Estévez D
- San José-Ruiz B
- Gil-Lemus MÁ
- Cercós-LLetí AC
- Esteban-Mensua MJ
- Díaz-Carrasco MS
Abstract
Extravasation is a potentially severe complication of intravenous administration of antineoplastic drugs. The limited data makes it difficult to develop an optimal management scheme. The objective of this study is to describe the clinical practice in the extravasation management of antineoplastic agents in Spanish centers.
Datos de la publicación
- ISSN/ISSNe:
- 1078-1552, 1477-092X
- Tipo:
- Article
- Páginas:
- 67-77
- PubMed:
- 37032471
- Factor de Impacto:
- 0,374 SCImago ℠
- Cuartil:
- Q3 SCImago ℠
JOURNAL OF ONCOLOGY PHARMACY PRACTICE SAGE PUBLICATIONS LTD
Citas Recibidas en Web of Science: 4
Documentos
- No hay documentos
Filiaciones
Keywords
- Extravasation, antidotes, antineoplastics, irritant, vesicant
Campos de Estudio
Cita
Jiménez I,ALBERT MA,Conde D,San José B,Gil MÁ,Cercós AC,Esteban MJ,Díaz MS. GEDEFO-SEFH management of antineoplastic extravasations survey results. J. Oncol. Pharm. Pract. 2023. 30. (1):p. 67-77. IF:1,000. (4).